Chandler Park: Informative talk by Hiba Khan on the PARP inhibitor combination trials

Chandler Park shared a post on X:

“Loved this informative talk by Dr. Hiba Khan, Fred Hutchinson Cancer Center. Updated table on the PARP inhibitor combination trials . Also a very thoughtful discussion for treatment escalation candidates for non-metastatic prostate cancer.”

Source: Chandler Park/X

More posts featuring Chandler Park on oncodaily.com

Chandler Park, MD, FACP is an haematologist oncologist, medical journalist, and clinical researcher. He is the Advisory Dean and Clinical Professor at University of Louisville School of Medicine. He is the Kentucky Physician Representative of the ASCO State Executive Council. He is also the Medical Oncology Board Examiner at American Board of Internal Medicine.

Hiba Khan, MD, MPH, is a physician at Fred Hutch and an Assistant Professor in both the Clinical Research Division at Fred Hutch and the Division of Hematology and Oncology at the University of Washington. She specializes in the treatment of cancers affecting the urinary and reproductive systems.